Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-06-14
2000-09-26
Higel, Floyd D.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
5483011, 5483044, 5483104, 514339, 514394, 544333, 5462737, C07D40102, C07D40104, C07D23520, C07D23518, A61K 3144, A61K 314184, A61K 2528
Patent
active
061244635
ABSTRACT:
The present invention describes novel benzimidazoles of formula: ##STR1## or pharmaceutically acceptable salt forms thereof, which are useful as CRF antagonists.
REFERENCES:
patent: 4797399 (1989-01-01), Ueda et al.
patent: 5015473 (1991-05-01), Chen
patent: 5075311 (1991-12-01), Hubsch et al.
patent: 5102880 (1992-04-01), Chakravarty et al.
patent: 5128327 (1992-07-01), Chakravarty et al.
patent: 5145959 (1992-09-01), Hubsch et al.
patent: 5157026 (1992-10-01), Chakravarty et al.
patent: 5171353 (1992-12-01), Fischer et al.
patent: 5176991 (1993-01-01), Jones et al.
patent: 5178997 (1993-01-01), Maskasky et al.
patent: 5183732 (1993-02-01), Maskasky
patent: 5185239 (1993-02-01), Maskasky
patent: 5187159 (1993-02-01), Greenlee et al.
patent: 5250408 (1993-10-01), Chang et al.
patent: 5250531 (1993-10-01), Cooper
patent: 5260322 (1993-11-01), Nakasima et al.
patent: 5272052 (1993-12-01), Maskasky
patent: 5312820 (1994-05-01), Ashton et al.
patent: 5319080 (1994-06-01), Leumann
patent: 5330989 (1994-07-01), Soll et al.
patent: 5332814 (1994-07-01), Moser
patent: 5332820 (1994-07-01), Duncia
patent: 5338740 (1994-08-01), Carpino et al.
patent: 5338756 (1994-08-01), Fortin et al.
patent: 5374638 (1994-12-01), Dhanoa et al.
patent: 5376665 (1994-12-01), Miyata et al.
patent: 5376666 (1994-12-01), Duncia
patent: 5385925 (1995-01-01), Narr et al.
patent: 5389509 (1995-02-01), Maskasky
patent: 5389634 (1995-02-01), Fortin et al.
patent: 5389641 (1995-02-01), Naka et al.
patent: 5393878 (1995-02-01), Leumann
patent: 5395840 (1995-03-01), Miiler et al.
patent: 5424432 (1995-06-01), Fredenburgh et al.
patent: 5428168 (1995-06-01), Whittaker et al.
patent: 5434150 (1995-07-01), Austel et al.
patent: 5444068 (1995-08-01), Heitsch et al.
patent: 5446159 (1995-08-01), Stucky et al.
patent: 5446160 (1995-08-01), Stucky et al.
patent: 5459147 (1995-10-01), Hauel et al.
patent: 5470867 (1995-11-01), Fortin et al.
patent: 5498715 (1996-03-01), Kuo et al.
patent: 5514682 (1996-05-01), Street
patent: 5541324 (1996-07-01), TenBrink et al.
patent: 5565437 (1996-10-01), Marquez et al.
patent: 5580981 (1996-12-01), Carpino
patent: 5587393 (1996-12-01), Narr et al.
patent: 5587470 (1996-12-01), Cook et al.
patent: 5597826 (1997-01-01), Howard et al.
patent: 5635525 (1997-06-01), Heitsch et al.
patent: 5684029 (1997-11-01), Narr et al.
Mataka et al, Reduction of 4,7-Diphenyl-1,2,5-thia(oxa)diazolo[3,4-c]pyridines Affording 2,5-Diphenyl-3,4-diaminopyridines and Ring Closure of the Diamines to Fluorescent Azaheterocycles, Jrnl of Heterocyclic Chem., 19/6,1481-1488, (1982).
Kalme et al, Nucleophilic Substitution in . . . , Khim Geterotsikl Soedin, 12, 1646-1650, (1992).
Kiyama et al., Synthesis and Evaluation of Novel Nonpeptide Angiotensin II Receptor Antagonists . . . , Chem. Pharm Bull., 43/3, 450-460, (1995).
Yashioka et al., New Synthetic Route to Imidazo[4,5-c]Pyridines By The Thermal Electrocycli Reaction of 1-Azahexatriene, Hetercycles, Vol. 41, No.1, 161 (1995).
Unknown, Mixtures of Perylene-Pigments For Use In A Photoconductive Element, Research Disclosure, Oct. 1991.
Beck James Peter
Curry Matthew Allen
Browder Monte R.
Dupont Pharmaceuticals
Higel Floyd D.
Rubin Kenneth B.
LandOfFree
Benzimidazoles as corticotropin release factor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazoles as corticotropin release factor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazoles as corticotropin release factor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2101313